HPS-062 - Efficacy and safety analysis between first-line immunotherapy and chemotherapy in patients with KRAS mutant non-small cell lung cancer (NSCLC)

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: HPS-062
• By: TANG, Yubo (The First Affiliated Hospital, Sun Yat-sen University, China)
• Co-author(s): Prof. Yubo Tang (The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China)
  Prof. Jia Li (The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China)
  Prof. Kejing Tang (The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China)
  
• Abstract:

  Introduction: One of the ongoing challenges we are dedicated to addressing is how to better integrate pharmacists into clinical diagnostic and treatment teams, cooperating with physicians to fully leverage pharmacists’ professional pharmaceutical expertise. This integration aims to enhance the level of rational drug use and improve..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login